"Thymidine Phosphorylase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine.
Descriptor ID |
D013939
|
MeSH Number(s) |
D08.811.913.400.725.850.500 D23.050.301.500.600.925 D23.050.705.552.600.850
|
Concept/Terms |
Thymidine Phosphorylase- Thymidine Phosphorylase
- Platelet-Derived Endothelial Cell Growth Factor
- Platelet Derived Endothelial Cell Growth Factor
- PD-ECGF
- Gliostatin
|
Below are MeSH descriptors whose meaning is more general than "Thymidine Phosphorylase".
Below are MeSH descriptors whose meaning is more specific than "Thymidine Phosphorylase".
This graph shows the total number of publications written about "Thymidine Phosphorylase" by people in this website by year, and whether "Thymidine Phosphorylase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 1 | 2 |
2002 | 2 | 1 | 3 |
2003 | 1 | 0 | 1 |
2004 | 2 | 2 | 4 |
2006 | 0 | 1 | 1 |
2007 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 1 | 1 | 2 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymidine Phosphorylase" by people in Profiles.
-
Successful liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Mol Genet Metab. 2020 05; 130(1):58-64.
-
Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma. Sci Transl Med. 2016 08 24; 8(353):353ra113.
-
Radiation recall gastritis secondary to erlotinib in a patient with pancreatic cancer. Anticancer Res. 2014 Dec; 34(12):7339-43.
-
Detection of uniparental isodisomy in autosomal recessive mitochondrial DNA depletion syndrome by high-density SNP array analysis. J Hum Genet. 2011 Dec; 56(12):834-9.
-
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine. J Clin Oncol. 2010 Oct 20; 28(30):4554-61.
-
Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival. Expert Opin Drug Saf. 2009 Sep; 8(5):507-14.
-
Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):853-60.
-
Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis. Cancer Invest. 2009 Feb; 27(2):193-200.
-
The use of capecitabine in the combined-modality therapy for rectal cancer. Clin Colorectal Cancer. 2008 Mar; 7(2):99-104.
-
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer. Clin Cancer Res. 2007 Jul 15; 13(14):4092-7.